Ebraheem M, Toghranegar J, Bensoussan Y, Templeton JMichael.
2026.
Explainable and Interpretable AI for Voice and Speech Analysis in Clinical Care: Systematic Review.. J Med Internet Res. 28:e83790.
Umesh A, Cordogan S, Simpson SK, Bram JT, Jones RH, Schairer WW, Sboner A, Elemento O, Green DW, Fabricant PD.
2026.
Genetic Variants Related to TGF-β Signaling Pathway Modulate Risk of Meniscus Injury: A Multiancestry Genome-wide Association Study.. Clin Orthop Relat Res. 484(1):178-193.
Okur V, Marcus A, Falcone JN, Hurd MA, Stewart SL, Claudio K, Manohar J, Dealla F, Kumar S, Yeung M et al..
2026.
Genome sequencing identifies monogenic causes in adults with metabolic diseases.. J Endocr Soc. 10(7):bvag091.
Uppal M, Bhinder B, Marderstein AR, Batlevi CLee, Falchi L, Hamlin P, Horwitz S, Kumar A, Noy A, Zelenetz AD et al..
2026.
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.. J Clin Oncol. :JCO2501928.
Anibal J, Nama GKrishna Ch, Ganesh S, Nafii Y, Cruz SSalvi, Daoud V, Zanin M, Le T, Khorrami P, Wood BJ et al..
2026.
Large Language Models for Optimizing Patient Recruitment Decisions in Voice Data Generation Projects.. Laryngoscope Investig Otolaryngol. 11(4):e70519.
Ruan J, Bond DA, Shah B, Allan JN, Rutherford SC, Gribbin C, Chen Z, Bhinder B, Tam W, Rossi D et al..
2026.
MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma.. Blood Adv. 10(4):1381-1394.
Kuo H-H, Bhinder B, Gokozan HN, Gorski K, Chandra P, Manohar J, Guevara D, Otilano J, Moyer J, Tranquille M et al..
2026.
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.. Sci Adv. 12(26):eadz3351.
Nazzaro M, Mardis ER, Canella A, Bhinder B, Elemento O, Behbehani G, Currier M, Glaspell A, Lee DA, Cripe TP et al..
2026.
Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progression.. Mol Ther Oncol. 34(1):201147.
Podaza E, Capuano J, Kuo H-H, Assaad MAl, Markowitz G, M Revuelta V, Nguyen J, Irizarry A, Ravichandran H, Ackermann S et al..
2026.
Tumor immune microenvironment reconstitution in patient-derived organoids enables therapy modeling for NSCLC.. Cell Rep Methods. :101339.
Purkayastha S, Park J, Beyer S, Chandra A, Markowitz SM, Lerman BB, Elemento O, Krumsiek J, Lo JC, Cheung JW.
2026.
Utilization of Serum Metabolomics and Polygenic Risk Scores in a Novel Risk Stratification Tool for the Prediction of Incident Atrial Fibrillation.. Circ Arrhythm Electrophysiol. :e013858.